Change search
ReferencesLink to record
Permanent link

Direct link
Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease
Umeå University, Faculty of Medicine, Department of Medical Biosciences.
Umeå University, Faculty of Medicine, Department of Medical Biosciences.
Umeå University, Faculty of Medicine, Department of Medical Biosciences.
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience.
Show others and affiliations
2016 (English)In: Journal of Clinical Investigation, ISSN 0021-9738, E-ISSN 1558-8238, Vol. 126, no 6, 2249-2253 p.Article in journal (Refereed) PublishedText
Abstract [en]

Amyotrophic lateral sclerosis (ALS) is an adult-onset degeneration of motor neurons that is commonly caused by mutations in the gene encoding superoxide dismutase 1 (SOD1). Both patients and Tg mice expressing mutant human SOD1 (hSOD1) develop aggregates of unknown importance. In Tg mice, 2 different strains of hSOD1 aggregates (denoted A and B) can arise; however, the role of these aggregates in disease pathogenesis has not been fully characterized. Here, minute amounts of strain A and B hSOD1 aggregate seeds that were prepared by centrifugation through a density cushion were inoculated into lumbar spinal cords of 100-day-old mice carrying a human SOD1 Tg. Mice seeded with A or B aggregates developed premature signs of ALS and became terminally ill after approximately 100 days, which is 200 days earlier than for mice that had not been inoculated or were given a control preparation. Concomitantly, exponentially growing strain A and B hSOD1 aggregations propagated rostrally throughout the spinal cord and brainstem. The phenotypes provoked by the A and B strains differed regarding progression rates, distribution, end-stage aggregate levels, and histopathology. Together, our data indicate that the aggregate strains are prions that transmit a templated, spreading aggregation of hSOD1, resulting in a fatal ALS-like disease.

Place, publisher, year, edition, pages
2016. Vol. 126, no 6, 2249-2253 p.
National Category
Medical Bioscience Neurosciences
URN: urn:nbn:se:umu:diva-122554DOI: 10.1172/JCI84360ISI: 000377027500021PubMedID: 27140399OAI: diva2:949867
Available from: 2016-07-25 Created: 2016-06-20 Last updated: 2016-07-25Bibliographically approved

Open Access in DiVA

fulltext(1009 kB)21 downloads
File information
File name FULLTEXT02.pdfFile size 1009 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ekhtiari Bidhendi, ElahehBergh, JohanZetterström, PerAndersen, Peter M.Marklund, Stefan L.Brännström, Thomas
By organisation
Department of Medical BiosciencesDepartment of Pharmacology and Clinical Neuroscience
In the same journal
Journal of Clinical Investigation
Medical BioscienceNeurosciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 21 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 73 hits
ReferencesLink to record
Permanent link

Direct link